BBV152
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BBV152, covering 2021-03-19 to 2023-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults [Phase 2, Phase 3]